agosti sec01 001-018 - lippincott williams &...

18
General Maps Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 1

Upload: others

Post on 06-Sep-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

General Maps

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 1

Page 2: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

2 C O M P L E M E N T C A S C A D E N O T E S

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 2

Page 3: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

3C O M P L E M E N T C A S C A D E

cascade is composed of serum complementproteins produced mainly by hepatocytes

complement activation occurs in 3 ways

MB-lectin pathway

acute phase protein calledmannan binding lectin (MBL)binds mannose residuesfound on pathogen surface

alternative pathway

complement protein C3 isspontaneously activated(usually by pathogen surface molecules) viahydrolysis

MBL is then bound byMBL associated serine protease (MASP) C3 directly binds pathogen surface

pathogen-MBL-MASPcomplex behaves just like C1s

leading to the formation ofC3 convertase

follows classic pathway fromthis point on

C3 forms

C3a =anaphylatoxin

C3b

C3b binds factor Band forms C3bB complex

C3bB complexis cleaved by factor D

into C3bBb

C3bBb behaves just likeC3 convertase

follows classic pathway fromthis point on

classic pathway

pathogen invades body

complement protein C1qbinds antibody-antigen complexfound on pathogen surface

C1q forms complementprotein C1s

C4b and C2b join to formC3 convertase

C2 intoC2b

C4 intoC4b

C4 into C4a =anaphylatoxin

C1s cleaves complementproteins:

C3 convertase cleavescomplement protein C3 into

C3a =anaphylatoxin

C3b also bindsC4b2a to formC4b2a3b or

C5 convertase

C5 convertase cleavescomplement protein C5 into

C5b binds C6to form C5bC6

C5bC6 binds C7to form C5b67

C5a =anaphylatoxin

cause more inflammationby binding and activatingother inflammatory cells

can lead toanaphylaxis

C5b67 bindsC8 to form

C5b678

C5b678 binds C9forming the

membrane attack complex

a pore forms inmembrane of pathogen

pore allows water and ionsinto organism causing

cell lysis

produces many molecules ofC3b which amplifies thecomplement cascaderesponse

C3b coats pathogenand marks it for phagocytosis =opsonization

complement cascadeis activated as part of theimmune response in order to:• mark pathogens for elimination by other cells of the immune system• lyse pathogens directly

both of these pathways occur without the help of antibodies = innate immune response

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 3

Page 4: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

4 C O A G U L AT I O N C A S C A D E N O T E S

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 4

Page 5: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

5C O A G U L AT I O N C A S C A D E

intrinsic pathway abnormalitiesmeasured byactivated partialthromboplastin time (aPTT)

intrinsicpathway

in response toinjury "within" bloodvessels:• damaged vessel endothelium• damaged platelets

in responseto tissue injury"outside" blood vessels

extrinsicpathway

begins by the creationof a complex between:

factor VII• calcium• tissue factor (TF)• thromboplastin

this complexactivatesfactor VII to VIIa

factor VIIa activates:

factor X to Xa

extrinsic pathwayabnormalitiesmeasured byprothrombin time (PT)

series of enzymatic reactionsthat occur within

secondary hemostasis (see map)in order to form fibrin

occurs on surfaceof activated platelets

and vascular endothelium

divided into 2interconnected pathways

begins by the creationof a complex on vascularsubendothelium between:

• factor XII (aka Hageman factor)• high molecular weight kininogen (HMWK)• Prekallikrein

this complexactivatesfactor XII to XIIa

factor XIIa activates:

Prekallikrein to kallikrein factor XI to XIa

kallikrein converts: factor XIa activatesfactor IX to IXa

plasminogen toplasminHMWK to bradykinin

leads to:• Ò vascular permeability• smooth muscle constriction• vascular vasodilation

activates complementcomponent C3 to C3a(see complement cascade map)

plasmin initiates fibrinolysisas it degrades fibrin intofibrin split products

fibrinolysis can bemeasured in lab as an Ò :• d-dimer level

IXa becomes apart of a new complexincluding:

• IXa• VIIIa• X

this complexactivatesX to Xa

Xa initiates thecommon pathwayby forming a complexbetween:

• Xa• Va• calcium• phospholipid

this complexcleavesprothrombin (factor II)into thrombin

fibrin is cross-linkedby factor XIIIa

amplifiesthe coagulation cascadeby activating factors:• V• VIII• XI• XIII

stimulatesplatelet aggregationand granule secretion(see hemostasis map)

permanent clot isformed as fibrincombines withplateletaggregates

common pathway abnormalitiesmeasured by both PT and aPTT

thrombin

main role ofthrombin is to convert

fibrinogen (factor I) to fibrin

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 5

Page 6: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

6 C E L L - M E D I AT E D I M M U N I T Y N O T E S

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 6

Page 7: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

7C E L L - M E D I AT E D I M M U N I T Y

first

exp

osur

e to

antig

en:

• int

race

llula

r• t

umor

cel

l

antig

en is

del

iver

ed to

seco

ndar

y ly

mph

oid

tissu

e

antig

en p

rese

ntin

g ce

ll (A

PC)

disp

lays

ant

igen

to n

aive

T c

ell v

iape

ptid

e: c

lass

I M

HC

com

plex

T ce

ll ac

tivat

ion

orpr

imin

g

activ

ated

T c

ell

unde

rgoe

s pr

olife

ratio

n, d

iffer

entia

tion

and

clon

al e

xpan

sion

into

ant

igen

spe

cific

effe

ctor

T c

ells

CD

4 he

lper

T c

ell

activ

ated

T c

ell

secr

etes

IL 2

prom

otes

furth

ercl

onal

exp

ansi

on

cyto

toxi

c C

D8

T ce

ll

activ

ates

end

othe

lium

enab

les

infla

mm

ator

yre

spon

se to

pro

gres

s(s

ee a

cute

infla

mm

atio

n m

ap)

prol

ifera

tion

of e

ffect

or T

cel

lpo

pula

tion

ampl

ifies

infla

mm

ator

yre

spon

se

trave

ls to

site

of in

fect

ion

rele

ases

cyt

okin

es s

uch

as:

• IFN

gam

ma

• TN

F al

pha

rele

ases

cyt

otox

ins

such

as:

• per

forin

• gra

nzym

es

kill

infe

cted

targ

et c

ell b

yin

duci

ngap

opto

sis

in 2

way

s:• c

ytot

oxin

s• F

as li

gand

IFN

gam

ma

enha

nces

act

ivat

ion

ofm

acro

phag

es

activ

ates

mac

roph

ages

via

IFN

gam

ma

and

CD

40 li

gand

mac

roph

ages

pha

gocy

tize

bact

eria

or o

ther

offe

ndin

g ag

ent

byst

ande

rtis

sue

dam

age

gran

ulom

a fo

rms

if m

acro

phag

esar

e un

able

to e

limin

ate

antig

en(s

ee s

arco

id a

nd T

B m

aps)

Ò e

xpre

ssio

nof

MH

C c

lass

IIm

olec

ules

and

B7

cost

imul

ator

y si

gnal

s

Ò a

ntig

enpr

esen

tatio

n to

T c

ells

ampl

ifies

imm

une

resp

onse

help

s T

cell

deve

lop

effe

ctor

func

tions

CD

4 T

cell

furth

erdi

ffere

ntia

tes

into

1 of

2 T

-hel

per c

ell t

ypes

if se

cret

es a

Th2

cel

l cyt

okin

epr

ofile

if se

cret

es a

Th1

cel

l cyt

okin

e pr

ofile

cell

med

iate

d in

flam

mat

ory

resp

onse

hum

oral

imm

une

resp

onse

( see

map

)

APC

als

o pr

ovid

es T

cel

lw

ith c

ostim

ulat

ory

sign

al (B

7 m

olec

ule)

bind

s C

D28

rece

ptor

on

T ce

ll

lack

of c

ostim

ulat

ory

sign

al c

ause

s an

ergy

=T

cell

unab

le to

resp

ond

to a

ntig

enic

stim

ulat

ion

activ

atio

n ph

ase

thes

e 2

path

way

s ar

e no

t alw

ays

mut

ually

exc

lusi

ve

effe

ctor

pha

se

effector functions include

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 7

Page 8: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

8 H U M O R A L I M M U N I T Y N O T E S

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 8

Page 9: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

9H U M O R A L I M M U N I T Y

first

exp

osur

e to

ant

igen

elic

its a

prim

ary

adap

tive

imm

une

resp

onse

2 ty

pes

of a

ntig

ense

en b

y B

cells

durin

g th

is re

spon

se

thym

us in

depe

nden

tan

tigen

s =

B ce

lls d

on't

need

T c

ell h

elp

toac

tivat

e

thym

us d

epen

dent

antig

ens

= B

cells

do

need

T c

ell h

elp

to a

ctiv

ate

antig

en is

del

iver

edto

lym

ph n

ode

whe

reit

is re

cogn

ized

by

both

B a

nd T

cel

ls

antig

en is

bou

nd b

y su

rface

IgM

on

naiv

e B

cel

l

antig

en is

proc

esse

d an

dpr

esen

ted

by A

PC to

naiv

e T

cells

CD

4 he

lper

T c

ells

activ

ated

secr

etes

Th2

cel

lcy

toki

ne p

rofil

e:• e

spec

ially

IL 4

secr

etes

Th1

cel

lcy

toki

ne p

rofil

e

cell-

med

iate

din

flam

mat

ory

resp

onse

(see

map

)

antig

en is

inte

rnal

ized

,pr

oces

sed

and

then

pres

ente

d on

aM

HC

cla

ss II

mol

ecul

eto

Th2

cel

l

linke

d re

cogn

ition

=ac

tivat

ion

of B

cel

l req

uire

s an

tigen

reco

gniti

onby

bot

h B

and

T ce

lls

T he

lper

cel

ls p

rodu

ceC

D40

liga

nd

CD

40 li

gand

on

T ce

llsbi

nds

CD

40 re

cept

or o

nB

cell

and

indu

ces

activ

atio

n of

the

B c

ell

B ce

lls fo

rm a

prim

ary

focu

sw

ithin

the

lym

ph n

ode

for c

lona

l exp

ansi

on(im

med

iate

resp

onse

)

enab

les

isot

ype

switc

hing

and

help

s th

e ge

rmin

al c

ente

rto

sur

vive

B ce

lls tr

avel

to p

rimar

y ly

mph

oid

folli

cle

form

a g

erm

inal

cen

ter w

here

antig

en s

peci

fic B

cel

ls c

alle

d ce

ntro

blas

ts p

rolif

erat

e

B ce

lls w

hich

hav

e a

less

erab

ility

to b

ind

the

antig

endi

e of

f with

in th

e ge

rmin

alce

nter

= n

egat

ive

sele

ctio

n

som

atic

hyp

erm

utat

ion

= cr

eate

s a

set o

f B c

ells

with

var

ying

abi

lity

to b

ind

the

sam

e an

tigen

occu

rs a

t the

sam

etim

e as

isot

ype

switc

hing

diffe

rent

cla

sses

of a

ntib

odie

ssp

ecifi

c fo

r the

sam

e an

tigen

are

prod

uced

resu

lts in

a s

mal

l num

ber o

f the

seB

cells

that

hav

e a

grea

ter a

bilit

y to

bind

the

antig

en =

affi

nity

mat

urat

ion

B ce

lls w

ith th

e hi

ghes

t affi

nity

for t

he a

ntig

enar

e se

lect

ed a

nd g

ive

rise

to b

oth

mem

ory

B c

ells

prov

ides

bod

y w

ithab

ility

to fi

ght f

utur

e ex

posu

reto

sam

e an

tigen

=se

cond

ary

adap

tive

imm

une

resp

onsepl

asm

a ce

lls

secr

etes

ant

ibod

ies

into

ser

um

allo

w fo

r2

mai

n ef

fect

or fu

nctio

nsof

B c

ells

to b

e ca

rried

out

agai

nst a

ntig

en

neut

raliz

epa

thog

ens

=bi

ndin

g an

d pr

even

ting

path

ogen

s fro

men

terin

g ce

lls

enab

leph

agoc

ytos

is v

ia2

way

s:• o

pson

izat

ion

• com

plem

ent

act

ivat

ion

(see

map

)

maj

ority

of a

ntig

ens

seen

by

B ce

lls

hum

oral

imm

une

resp

onse

cann

ot b

egin

with

out B

and

T c

ell c

oope

ratio

n

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 9

Page 10: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

10 A C U T E I N F L A M M AT I O N N O T E S

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 10

Page 11: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

11A C U T E I N F L A M M AT I O N

• inf

ectio

n• t

raum

a• e

xpos

ure

to p

hysi

cal o

r che

mic

al a

gent

s• t

issu

e ne

cros

is• f

orei

gn b

odie

s• h

yper

sens

itivi

ty re

actio

ns (s

ee m

aps)

• end

othe

lial i

njur

y

insu

lt el

icits

an

imm

edia

te re

spon

se (i

n se

cond

s to

min

utes

)by

bod

y's

imm

une

syst

em =

acut

e in

flam

mat

ion

3 m

ain

com

pone

nts

begi

ns w

ithac

tivat

ion

of e

ndot

heliu

m

vasc

ular

reac

tion

=de

liver

s pl

asm

a pr

otei

nsan

d im

mun

e ce

lls to

site

of in

flam

mat

ion

cellu

lar r

eact

ion

=le

ukoc

yte

extra

vasa

tion

and

activ

atio

n

leuk

ocyt

e m

argi

natio

n

leuk

ocyt

e ro

lling

and

pave

men

ting

leuk

ocyt

e ad

hesi

on

3. le

ukoc

yte

mig

ratio

n or

dia

pede

sis

thro

ugh

endo

thel

ium

chem

otax

is to

war

dsi

te o

f inj

ury

or in

fect

ion

leuk

ocyt

e ac

tivat

ion

and

phag

ocyt

osis

elim

inat

ion

of o

ffend

ing

agen

t

lead

s to

1 o

f 3 o

utco

mes

:• r

esol

utio

n• h

ealin

g w

ith fi

bros

is• p

rogr

essi

on to

chr

onic

infla

mm

atio

n (s

ee m

ap)

tissu

e in

jury

chem

ical

sig

nals

for c

hem

otax

is p

rovi

ded

by:

• bac

teria

l pro

duct

s• a

naph

ylot

oxin

s (C

5a)

• leu

kotri

enes

• cyt

okin

es

2. Ò

blo

od fl

ow a

nd v

isco

sity

med

iate

d pr

imar

ily b

y:• h

ista

min

e• n

itric

oxi

de

brad

ykin

in fr

omac

tivat

ion

of th

eki

nin

syst

em

1. in

crea

sed

vasc

ular

perm

eabi

lity

via:

• end

othe

lial c

ontra

ctio

n• d

irect

inju

ry• l

euko

cyte

indu

ced

inju

ry• a

ngio

gene

sis-

rela

ted

leak

age

bloo

d vi

scos

ity Ò

as e

xuda

te e

scap

esin

to s

urro

undi

ng ti

ssue

vaso

dila

tion

exud

ate

cont

ains

com

plem

ent p

rote

ins

whi

ch c

an b

ecom

e ac

tivat

ed(s

ee c

ompl

emen

t cas

cade

map

)

elab

orat

es th

e ac

ute

infla

mm

ator

y re

spon

se v

ia:

• Ò v

ascu

lar p

erm

eabi

lity

• leu

kocy

te a

dhes

ion,

che

mot

axis

and

act

ivat

ion

• pha

gocy

tosi

s vi

a op

soni

zatio

n

bloo

d st

asis

allo

ws

leuk

ocyt

es to

colle

ct a

long

vas

cula

ren

doth

eliu

m

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11

Page 12: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

12 C H R O N I C I N F L A M M AT I O N N O T E S

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 12

Page 13: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

13C H R O N I C I N F L A M M AT I O N

continuous activation of T cells

release ofIFN gamma

work in concert toÒ intracellularadhesion

Ò inflammatorycell recruitment andexacerbates inflammatory response

leads to a state of chronic inflammation

accumulation and activation ofmacrophages

cytokines releasedtissue wasting Ò microbicidal

activity Ò cytokine releaseÒ expression ofMHC II molecules

Ò antigenpresenting cellfunctions

release ofTNF α

fibroblast proliferationtissue damage

release ofreactive oxygen speciesand reactive nitrogen species

collagen production

fibrosis

alters structureand function ofinvolved tissues

regardless of etiologyantigen is unable tobe cleared by immunesystem

etiologies include:• ongoing infection• acute inflammation• tissue damage from chronic disease• toxic exposure• autoimmunity• malignancy

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 13

Page 14: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

14 R E N I N - A N G I OT E N S I N - A L D O S T E R O N E S YS T E M N O T E S

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 14

Page 15: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

15R E N I N - A N G I OT E N S I N - A L D O S T E R O N E S YS T E M

Ú in circulatingblood volume due to:• hypovolemia• Ú total peripheral resistance (TPR)• congestive heart failure (CHF)

kidneys senseÚ blood volume

via 3 mainmechanisms

Ú stretch ofrenal baroreceptorsin afferent arterioles

Ú NaCl deliveryand reabsorption

across macula densa

Ú stretch ofbaroreceptors

in central arterialcirculation

causes Úin calcium concentration

leads to renin releasedby JGA cells into

circulationAT IIsuppresses reninrelease

renin is cleavedby angiotensinogeninto angiotensin I

(inactive form)

stimulation of the AT I receptorcauses multiple

short term physiologicactions which Ò

the circulating volume

Ò sympathetic outflowto beta receptors on

juxtaglomerular cells (JGA)

AT I travels to lungswhere it is cleaved by ACE

into AT II (active form)

ACE cleavesbradykinin

bradykinin

kininogen

kallikrein

inactivepeptides

AT I receptor located in:• vasculature• kidney• adrenals• heart• brain

bradykinin:• vasodilates• decreases platelet aggregation

AT II receptors located in:• vascular endothelium• brain• adrenal glands

opposite affect of AT I

Ò bradykinin

Ò risk of:• atherosclerosis• blood clots

inhibits:• TPA• UPA• protein C

Ò plasminogen activator inhibitor-I(PAI-I )

othereffects

long-term physiologic actionslead to structural changesand disease

• fibrosis• inflammation• hypertrophy

• thrombosis• hypertrophy• vasoconstriction• intimal thickening• hypertrophy of smooth muscle cells

• hypertrophy of myocytes• Ò matrix formation• fibrosis

worsens chronickidney disease(see map)

worsening hypertensionand vascular disease(see maps)

worsensheart failure(see map)

Ò afterloadon heart

Ò peripheralvascular

resistance

smooth muscleconstrictionin systemicvasculature

Ò myocardialcontractility

Ò risk ofarrhythmias

Ò adrenergictone

enhancesrelease of catecholamines

from adrenal medulla

Ò in:• nitric oxide• cyclic GMP

acts onhypothalamus

to stimulate thirstand ADH release

Ò intotal bodyfree water

acts onzona glomerulosaof adrenal cortex

to releasealdosterone

Ò sodiumreabsorption

at distal tubules

Ò fluidreabsorpbtion

causes constriction ofefferent arterioles

more than afferent arteriolesto Ò perfusion pressure

Ò water andsodium

reabsorption

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 15

Page 16: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

16 H E M O S TA S I S N O T E S

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 16

Page 17: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

17H E M O S TA S I S

norm

al e

ndot

heliu

mdo

es n

ot a

llow

inac

tivat

ed p

late

lets

to a

dher

e

1. a

nti-p

late

let f

unct

ions

endo

thel

ium

syn

thes

is o

fni

tric

oxi

de a

nd p

rost

acyc

lin (P

GI2

)ca

uses

:• v

asod

ilatio

n• i

nhib

ition

of p

late

let a

ggre

gatio

n

expr

essi

on o

f ade

nosi

nedi

phos

phat

ase

whi

ch d

egra

des

ADP

and

prev

ents

pla

tele

t agg

rega

tion

inhi

bits

coa

gula

tion

casc

ade

fact

ors:

Va VIIIa

activ

atio

n of

pro

tein

C(s

ee c

oagu

latio

nca

scad

e m

ap)

thro

mbo

mod

ulin

bin

dsan

d co

nver

ts th

rom

bin

into

an a

ntic

oagu

lant

2. a

nti-c

oagu

lant

func

tions

3. fi

brin

olyt

icfu

nctio

ns

synt

hesi

zes

tissu

e ty

pepl

asm

inog

en a

ctiv

ator

(t-P

A)w

hich

hel

ps to

cle

ar fi

brin

dep

osits

from

the

endo

thel

ium

by

activ

atin

gpl

asm

inog

en to

pla

smin

allo

ws

for l

iqui

d bl

ood

flow

via

3 m

ajor

mec

hani

sms:

tissu

e fa

ctor

path

way

inhi

bito

r

endo

thel

ium

mem

bran

eas

soci

ated

hep

arin

-like

mol

ecul

es a

ugm

ent

antit

hrom

bin

III

inac

tivat

eco

agul

atio

n fa

ctor

s:• X

a, IX

a, X

Ia, X

IIa• t

hrom

bin

the

pref

erre

d st

ate

unde

rno

rmal

con

ditio

ns

norm

al h

emos

tasi

s =

bala

nce

betw

een

anti-

and

pro

-thro

mbo

ticfu

nctio

ns

anti-

thro

mbo

tic fu

nctio

nspr

o-th

rom

botic

func

tions

occu

r in

resp

onse

toin

jure

d va

scul

aren

doth

eliu

m

loca

l neu

rohu

mor

al fa

ctor

sca

use

trans

ient

arte

rial

vaso

cons

trict

ion

synt

hesi

zes

tissu

e fa

ctor

thro

mbo

geni

c su

bsta

nces

of

the

sube

ndot

helia

l ext

ra c

ellu

lar m

atrix

expo

sed

to b

lood

flow

plat

elet

s ad

here

via

vW

F to

inju

red

endo

thel

ium

and

bec

ome

activ

ated

secr

ete

gran

ules

con

tain

ing

ADP,

thro

mbo

xane

A2

whi

ch le

ad to

:

coag

ulat

ion

casc

ade

(see

map

) casc

ade

ultim

atel

yac

tivat

es th

rom

bin

thro

mbi

n co

nver

tsfib

rinog

en in

to fi

brin

loca

l fib

rin d

epos

ition

occ

urs

at th

e si

te o

f vas

cula

r inj

ury

fibrin

and

pla

tele

t agg

rega

tes

com

bine

to fo

rma

perm

anen

t plu

g

thro

mbi

n al

sore

crui

ts m

ore

plat

elet

s an

dle

ads

to fu

rther

gran

ule

rele

ase

prev

ents

furth

erhe

mor

rhag

e

recr

uitm

ent o

fm

ore

plat

elet

s an

dpl

atel

etag

greg

atio

n

prim

ary

hem

osta

sis

secondary hemostasis

form

atio

n of

ahe

mos

tatic

plug

Ú th

rom

bin

form

atio

n

allo

ws

for

Ò fi

brin

olys

is

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 17

Page 18: Agosti Sec01 001-018 - Lippincott Williams & Wilkinsdownloads.lww.com/.../samples/Agosti_Sec01_001-018.pdf · Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 11. 12 CHRONIC INFLAMMATIONNOTES

Agosti_Sec01_001-018.qxd 2/21/07 7:56 PM Page 18